Published in Hepatology on September 01, 2004
Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med (2012) 2.33
Mechanisms of hypoxemia. Lung India (2017) 2.01
Hepatopulmonary Syndrome. Dig Dis Sci (2015) 1.10
Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol (2012) 1.05
The role of garlic in hepatopulmonary syndrome: a randomized controlled trial. Can J Gastroenterol (2010) 0.95
The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci (2007) 0.86
Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature. J Clin Transl Hepatol (2016) 0.81
Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS). PLoS One (2014) 0.81
Extracorporeal membrane oxygenation as a bridge to liver transplantation for acute respiratory distress syndrome-induced life-threatening hypoxaemia aggravated by hepatopulmonary syndrome. Crit Care (2011) 0.81
Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.79
Cirrhosis and hepatopulmonary syndrome. World J Gastroenterol (2014) 0.77
The hepatopulmonary syndrome. Arq Bras Cir Dig (2014) 0.77
Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77
The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease. Clin Gastroenterol Hepatol (2015) 0.76
Hepatopulmonary syndrome: What we know and what we would like to know. World J Gastroenterol (2016) 0.75
Hepatobiliary Quiz (Answers)-16 (2015). J Clin Exp Hepatol (2015) 0.75
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: a case report and review of the literature. World J Gastroenterol (2006) 0.75
Pulmonary complications of hepatic diseases. World J Gastroenterol (2016) 0.75
Refractory hypoxemia caused by hepatopulmonary syndrome: a case report. J Med Case Rep (2014) 0.75
[Pulmonary complications of liver cirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax]. Internist (Berl) (2010) 0.75
Noninvasive assessment of liver fibrosis. Hepatology (2010) 3.86
Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol (2009) 3.75
Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology (2010) 3.45
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl (2006) 3.29
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology (2007) 3.19
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology (2002) 2.93
Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med (2009) 2.70
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study. J Hepatol (2008) 2.63
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol (2003) 2.35
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology (2002) 2.15
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology (2007) 2.07
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology (2006) 2.03
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed (2006) 1.89
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol (2004) 1.82
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology (2006) 1.66
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl (2004) 1.65
Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology (2004) 1.65
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology (2006) 1.64
Viral hepatitis in liver transplantation. Gastroenterology (2012) 1.59
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J (2013) 1.57
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat (2006) 1.53
Determination of IL28B polymorphisms in liver biopsies obtained after liver transplantation. J Hepatol (2011) 1.50
[Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires]. Med Clin (Barc) (2007) 1.48
Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema. Am J Respir Crit Care Med (2014) 1.48
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration (2006) 1.47
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension. Liver Transpl (2007) 1.44
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl (2009) 1.43
Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.41
Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2007) 1.40
[Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy]. Arch Bronconeumol (2010) 1.39
[Liver abscesses following liver transplantation from non-heart-beating donation]. Med Clin (Barc) (2010) 1.39
Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985) (2009) 1.38
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology (2005) 1.35
Physical activity and clinical and functional status in COPD. Chest (2009) 1.34
Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med (2007) 1.33
Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period. J Hepatol (2012) 1.26
Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2005) 1.25
Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol (2011) 1.21
ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol (2012) 1.15
Varicose vein surgery: stripping versus the CHIVA method: a randomized controlled trial. Ann Surg (2010) 1.14
The role of external and matrix pH in mitochondrial reactive oxygen species generation. J Biol Chem (2008) 1.13
A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol (2011) 1.13
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
Prolonged respiratory symptoms in clean-up workers of the prestige oil spill. Am J Respir Crit Care Med (2007) 1.11
Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia. PLoS Comput Biol (2009) 1.10
Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation. Am J Pathol (2004) 1.10
Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology (2010) 1.10
Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet (2010) 1.08
The expanding horizons of endobronchial ultrasound: diagnosis of a tumor embolism. Chest (2012) 1.06
Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J (2012) 1.05
Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res (2010) 1.05
Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol (2011) 1.01
Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology (2005) 1.01
Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation (2004) 1.00
The SERPINE2 gene and chronic obstructive pulmonary disease. Am J Hum Genet (2006) 0.99
Telemedicine enhances quality of forced spirometry in primary care. Eur Respir J (2011) 0.99
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J (2012) 0.96
Severe acute hepatitis in the DRESS syndrome: Report of two cases. Ann Hepatol (2010) 0.96
Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol (2002) 0.96
Clinical Decision Support Systems (CDSS) for preventive management of COPD patients. J Transl Med (2014) 0.96
The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research. J Transl Med (2014) 0.95
Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig. Respir Res (2009) 0.95
Physical activity in COPD patients: patterns and bouts. Eur Respir J (2012) 0.95
Synergy-COPD: a systems approach for understanding and managing chronic diseases. J Transl Med (2014) 0.94
Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab (2003) 0.94
The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study. BMC Med Genet (2011) 0.93
Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat? J Hepatol (2006) 0.92
Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med (2011) 0.92
Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil (2009) 0.92
Compartmentation of glycogen metabolism revealed from 13C isotopologue distributions. BMC Syst Biol (2011) 0.92
Retransplantation in patients with hepatitis C recurrence after liver transplantation. J Hepatol (2010) 0.91
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med (2010) 0.91
Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985) (2013) 0.91
Acute and long-term effects of inhaled iloprost in portopulmonary hypertension. Liver Transpl (2010) 0.91
Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J (2012) 0.90
Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation. Gastroenterology (2009) 0.89
Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation. Liver Transpl (2009) 0.89
Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study. Respir Med (2004) 0.89
Modeling of spatial metabolite distributions in the cardiac sarcomere. Biophys J (2007) 0.89
Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation (2002) 0.88
Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact. Am J Gastroenterol (2006) 0.88
Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest (2005) 0.88
Network medicine analysis of COPD multimorbidities. Respir Res (2014) 0.87
Infection during natural orifice transluminal endoscopic surgery peritoneoscopy: a randomized comparative study in a survival porcine model. J Minim Invasive Gynecol (2011) 0.87
[Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients]. Arch Bronconeumol (2011) 0.87
Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension. Respir Med (2004) 0.87
The impact of home hospitalization on healthcare costs of exacerbations in COPD patients. Eur J Health Econ (2007) 0.87
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol (2012) 0.87
Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins. PLoS One (2012) 0.86
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation (2013) 0.86